Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Adenocarcinoma 7Neoplasms 6Stomach Neoplasms 5Solid Tumors 2Pancreatic Neoplasms 1Metastatic Pancreatic Adenocarcinoma 1Esophageal Neoplasms 1CLDN18.2-positive Gastric Adenocarcinoma 1CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction 1Adenocarcinoma Of Esophagus 1

Interventions

Fluorouracil 3irinotecan sucrosofate 2Leucovorin 2zolbetuximab 1pembrolizumab 1beta-D-glucosylisophosphoramide mustard 1Drug Therapy 14-fluorobenzoyl-TN-14003 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Metastatic Pancreatic Adenocarcinoma × zolbetuximab × Clear all
NCT06396091 2025-11-13

A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer

Astellas Pharma Inc

Phase 1 Active not recruiting
12 enrolled
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡